心臓POC検査機器市場：製品タイプ、用途、エンドユーザー別-2025年～2030年の世界予測

心臓POC検査機器市場は、2023年に13億6,000万米ドルと評価され、2024年には15億2,000万米ドルに達すると予測され、CAGR 12.36％で成長し、2030年には30億8,000万米ドルに達すると予測されています。

心臓POC（Point-of-Care）検査機器は、集中的な検査施設に頼るのではなく、患者の治療現場で直接、心臓マーカーを迅速かつ正確に評価するために設計された携帯型医療診断ツールです。これらの機器は、緊急時に迅速な検査結果を提供し、急性心筋梗塞の場合など、ヘルスケアプロバイダーがタイムリーな判断を下せるよう支援するために極めて重要です。使いやすさと専門検査施設に依存しないことから、病院、診療所、外来診療、在宅医療など、さまざまな場面で応用されています。市場の成長は、心血管疾患の有病率の上昇、迅速な診断ソリューションに対する需要の増加、患者管理の分散化に向けた世界的動向の影響を主に受けています。バイオマーカー探索とマイクロ流体工学の革新がこの分野の技術進歩を促進し、応用範囲をさらに拡大し、新規参入企業にも既存企業にも有利な機会を提供しています。しかし、厳しい規制要件、高額な装置コスト、実験室以外の環境での検査精度や信頼性に関する問題など、課題も残っています。アジア太平洋やラテンアメリカなど、ヘルスケアインフラの需要が急増している地域は、市場浸透と成長の大きな可能性を秘めています。さらに、医療ITシステムとの統合など、機器の小型化と接続性の強化に焦点を当てた共同研究開発の取り組みは、差別化と市場リーダーシップの道を提供します。企業は、遠隔医療や遠隔モニタリングをサポートするコネクテッドPOCソリューションを開発することで、デジタルヘルス動向を活用し、進化する患者ケアモデルに対応すべきです。技術革新の鍵となる分野は、POC機器で利用可能な検査パネルの信頼性と幅を強化し、包括的でより正確な心臓診断を可能にすることにあります。予測ヘルスケアのためのAI主導型アナリティクスへの継続的な投資は、競合情勢において企業をさらに有利に位置づけることができます。

市場力学：急速に進化する心臓POC検査機器市場の主要市場インサイトを公開

心臓POC検査機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心臓疾患の有病率と老年人口の増加
  • 患者の早期発見・診断への傾斜
  • 心臓の健康に対する政府の好意的な支援
• 市場抑制要因
  • 心臓POC検査機器における製品回収の潜在的リスク
• 市場機会
  • ユニークで新しいトロポニンベースの検査の実施
  • 積極的な投資と新興企業エコシステム
• 市場の課題
  • 心臓POC検査機器の精度に関する限界と懸念

ポーターの5つの力：心臓POC検査機器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、心臓POC検査機器市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓POC検査機器市場における外部からの影響の把握

外部マクロ環境要因は、心臓POC検査機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓POC検査機器市場における競合情勢の把握

心臓POC検査機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓POC検査機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓POC検査機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心臓POC検査機器市場における成功への道筋を描く

心臓POC検査機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に心臓疾患の有病率と高齢者人口の増加
    • 患者の早期発見と診断への傾向
    • 心臓の健康に対する政府の好意的な支援
  • 抑制要因
    • 心臓POC検査機器における製品リコールの潜在的リスク
  • 機会
    • 独自の新しいトロポニンベースの検査の導入
    • 積極的な投資とスタートアップエコシステム
  • 課題
    • 心臓POC検査機器の正確性に関する制限と懸念事項
• 市場セグメンテーション分析
  • 製品：さまざまな心臓POC検査機器に対する規制当局の承認
  • デバイスタイプ：心臓病の管理に便利な在宅ケアを提供するウェアラブルPOCデバイスの調査
  • 応用：心臓病の管理において効果的な診断とスクリーニング手順が果たす重要な役割
  • エンドユーザー：心臓の健康を改善するために病院が提供する広範かつ包括的なケア
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心臓POC検査機器市場：製品別

• 心臓バイオマーカー検査
  • B型ナトリウム利尿ペプチド
  • クレアチンキナーゼ-MB[CK-MB]画分
  • Dダイマー検査
  • ミオグロビン検査
  • トロポニン検査
• 消耗品とアクセサリ
• デバイス
  • アナライザー
  • イメージングおよびモニタリングデバイス

第7章 心臓POC検査機器市場：デバイスタイプ別

• ベンチトップPOCデバイス
• ハンドヘルドPOCデバイス
• ウェアラブルPOCデバイス

第8章 心臓POC検査機器市場：用途別

• 診断とスクリーニング
• 監視

第9章 心臓POC検査機器市場：エンドユーザー別

• 外来手術センター
• 診断検査室
• ホーム設定
• 病院

第10章 南北アメリカの心臓POC検査機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の心臓POC検査機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの心臓POC検査機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • シーメンスヘルシナーズ、心不全診断の強化と患者ケアの迅速化を目指してアテリカプラットフォームでNT-proBNPIIアッセイを開始
  • F.ホフマン・ラ・ロシュAGは、糖尿病患者のCVDおよび心不全の早期発見と管理を強化するために、コバス H 232でNT-proBNPポイントオブケア検査を開始しました。
  • Analytics for LifeとCorVista Healthが肺高血圧症の非侵襲性CorVistaシステムのFDA認可を取得
  • Eko Health, Inc.とメイヨークリニックがAIによる低駆出率検出のFDA認可を取得
  • SpinChip Diagnostics、次世代の心臓POC検査機器を商業化するためにbioMerieuxから1億1,500万ノルウェークローネの投資を受ける
  • ロシュ、心臓血管診断の進歩に向けルミラDxのマイクロ流体ポイントオブケア技術を買収
  • プライマリーヘルステックのモビラボデバイスは、IoT統合により心臓病や慢性疾患の早期発見を可能にします
  • EDX Medical Group Plc.がHutano Diagnostics Ltd.を買収し、高度なスマートフォン統合型POCテストを開発
  • EDXメディカルグループがHutano Diagnosticsを買収し、スピード、精度、コスト効率を向上させる高度な診断技術で迅速なヘルスケア検査に革命を起こす
  • Ciplaは、CE IVD承認を取得して診断ポートフォリオを拡大し、迅速な臨床意思決定と市場浸透を強化するPOC検査デバイス cippointを発売しました。
• 戦略分析と提言
  • F.ホフマン・ラ・ロシュ株式会社
  • シーメンスヘルシナーズ AG
  • アボットラボラトリーズ
  • ダナハーコーポレーション
  • ヴェルフェン、S.A.

企業一覧

• Abbott Laboratories
• ACON Laboratories, Inc.
• Alfa Scientific Designs, Inc.
• Bio-Rad Laboratories, Inc.
• Cipla Limited
• Compagnie Merieux Alliance SAS
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Getein Biotech, Inc.
• Laboratory Corporation of America Holdings
• LifeSign LLC
• Medtronic plc
• Merck KGaA
• Nano-Ditech Corp.
• Nexus Dx, Inc.
• Nova Biomedical Corporation
• Polymer Technology Systems, Inc. by Sinocare
• Precision Biosensor, Inc.
• QuidelOrtho Corporation
• Sekisui Chemical Co., Ltd.
• Siemens Healthineers AG
• Werfen, S.A.

LIST OF FIGURES

• FIGURE 1. CARDIAC POC TESTING DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. CARDIAC POC TESTING DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
• FIGURE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 6. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 14. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 16. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 18. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 22. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIAC POC TESTING DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
• TABLE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 6. CARDIAC POC TESTING DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CREATINE KINASE-MB [CK-MB] FRACTION, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY D-DIMER TESTS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MYOGLOBIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CONSUMABLE & ACCESSORIES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 16. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 17. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 18. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMAGING & MONITORING DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 19. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 20. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 21. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY BENCH-TOP POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 22. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HANDHELD POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 23. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY WEARABLE POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 24. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 25. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTICS & SCREENING, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 26. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 27. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 28. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 29. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 30. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 31. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 32. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 33. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 34. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 35. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 36. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 37. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 38. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 39. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 40. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 41. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 42. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 43. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 44. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 45. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 46. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 47. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 48. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 49. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 50. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 51. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 52. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 53. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 54. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 55. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 56. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 57. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 58. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 59. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 60. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 61. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 62. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 63. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 64. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 65. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 66. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 67. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 68. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 69. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
• TABLE 70. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 71. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 72. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 73. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 74. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 75. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 76. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 77. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 78. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 79. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 80. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 81. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 82. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 83. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 84. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 85. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 86. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 87. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 88. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 89. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 90. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 91. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 92. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 93. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 94. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 95. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 96. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 97. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 98. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 99. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 100. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 101. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 102. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 103. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 104. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 105. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 106. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 107. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 108. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 109. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 110. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 111. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 112. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 113. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 114. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 115. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 116. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 117. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 118. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 119. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 120. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 121. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 122. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 123. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 124. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 125. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 126. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 127. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 128. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 129. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 130. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 131. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 132. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 133. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 134. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 135. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 136. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 137. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 138. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 139. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 140. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 141. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 142. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 143. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 144. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 145. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 146. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 147. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 148. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 156. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 157. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 158. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 159. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 160. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 161. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 162. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 163. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 164. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 165. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 166. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 167. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 168. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 169. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 170. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 171. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 172. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 173. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 174. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 175. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 176. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 177. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 178. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 179. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 180. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 181. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 182. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 183. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 184. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 185. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 186. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 187. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 188. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 189. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 190. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 191. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 192. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 193. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 194. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 195. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 196. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 197. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 198. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 199. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 200. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 201. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 202. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 203. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 204. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 205. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 206. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 207. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 208. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 209. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 210. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 211. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 212. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 213. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 214. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 215. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 216. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 217. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 218. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 219. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 220. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 221. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 222. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 223. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 224. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 225. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 226. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 227. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 228. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 229. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 230. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 231. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 232. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 233. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 234. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 235. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 236. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 237. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 238. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 239. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 240. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 241. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 242. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 243. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 244. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 245. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 246. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 247. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 248. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 249. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 250. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 251. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 252. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 253. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 254. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 255. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 256. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 257. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 258. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 259. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 260. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 261. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 262. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 263. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 264. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 265. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 266. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 267. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 268. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 269. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 270. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 271. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 272. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 273. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 274. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 275. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 276. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 277. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 278. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 279. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 280. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 281. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 282. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 283. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiac POC Testing Devices Market was valued at USD 1.36 billion in 2023, expected to reach USD 1.52 billion in 2024, and is projected to grow at a CAGR of 12.36%, to USD 3.08 billion by 2030.

Cardiac Point-of-Care (POC) testing devices are portable medical diagnostic tools designed for quick and accurate assessment of cardiac markers directly at the site of patient care, rather than relying on centralized laboratory facilities. These devices are crucial in emergencies to provide rapid test results, assisting healthcare providers in making timely decisions, such as in cases of acute myocardial infarction. Their application extends across various settings, including hospitals, clinics, ambulatory care, and even home healthcare, thanks to their ease of use and non-reliance on specialized laboratories. Market growth is predominantly influenced by the rising prevalence of cardiovascular diseases, the increasing demand for rapid diagnostic solutions, and a worldwide trend towards decentralized patient management. Innovations in biomarker discovery and microfluidics are driving technological advancements in this sector, further expanding its application scope, and providing lucrative opportunities for new entrants and existing players alike. However, challenges remain due to stringent regulatory requirements, high device costs, and issues related to testing accuracy and reliability in non-laboratory settings. Regions with a burgeoning demand for healthcare infrastructure, such as Asia-Pacific and Latin America, present significant potential for market penetration and growth. Moreover, collaborative R&D efforts focusing on device miniaturization and connectivity enhancements, such as integration with health IT systems, offer avenues for differentiation and market leadership. Companies should capitalize on digital health trends by developing connected POC solutions that support telemedicine and remote monitoring, thus aligning with evolving patient care models. A key area for innovation lies in enhancing the reliability and breadth of the test panel available on POC devices, enabling comprehensive and more precise cardiac diagnostics. Continuous investment in AI-driven analytics for predictive healthcare can further position players favorably in the competitive landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac POC Testing Devices Market

The Cardiac POC Testing Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of cardiac disorders and rising geriatric population globally
  • Inclination toward the early detection and diagnosis of patients
  • Favorable government support for cardiac health
• Market Restraints
  • Potential risk of product recall in Cardiac POC testing devices
• Market Opportunities
  • Implementation of unique & new troponin-based test
  • Positive investment and startup ecosystem
• Market Challenges
  • Limitations and concerns associated with the accuracy of cardiac POC testing devices

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac POC Testing Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac POC Testing Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac POC Testing Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac POC Testing Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac POC Testing Devices Market

A detailed market share analysis in the Cardiac POC Testing Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac POC Testing Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac POC Testing Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac POC Testing Devices Market

A strategic analysis of the Cardiac POC Testing Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac POC Testing Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Cipla Limited, Compagnie Merieux Alliance SAS, Danaher Corporation, F. Hoffmann-La Roche Ltd, Getein Biotech, Inc., Laboratory Corporation of America Holdings, LifeSign LLC, Medtronic plc, Merck KGaA, Nano-Ditech Corp., Nexus Dx, Inc., Nova Biomedical Corporation, Polymer Technology Systems, Inc. by Sinocare, Precision Biosensor, Inc., QuidelOrtho Corporation, Sekisui Chemical Co., Ltd., Siemens Healthineers AG, and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the Cardiac POC Testing Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cardiac Biomarker Test, Consumable & Accessories, and Devices. The Cardiac Biomarker Test is further studied across B-Type Natriuretic Peptide, Creatine Kinase-MB [CK-MB] Fraction, D-dimer Tests, Myoglobin Tests, and Troponin Tests. The Devices is further studied across Analyzers and Imaging & Monitoring Devices.
• Based on Device Type, market is studied across Bench-top POC Devices, Handheld POC Devices, and Wearable POC Devices.
• Based on Application, market is studied across Diagnostics & Screening and Monitoring.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Home Settings, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of cardiac disorders and rising geriatric population globally
    • 5.1.1.2. Inclination toward the early detection and diagnosis of patients
    • 5.1.1.3. Favorable government support for cardiac health
  • 5.1.2. Restraints
    • 5.1.2.1. Potential risk of product recall in Cardiac POC testing devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Implementation of unique & new troponin-based test
    • 5.1.3.2. Positive investment and startup ecosystem
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations and concerns associated with the accuracy of cardiac POC testing devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Favorable regulatory approvals for various cardiac POC testing devices
  • 5.2.2. Device Type: Exploration of wearable POC devices to provide convenient homecare for managing heart conditions
  • 5.2.3. Application: Critical role played by effective diagnostics & screening procedures in the management of cardiac diseases
  • 5.2.4. End-User: Extensive and comprehensive care provided by hospitals for improving cardiac health
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac POC Testing Devices Market, by Product

• 6.1. Introduction
• 6.2. Cardiac Biomarker Test
  • 6.2.1. B-Type Natriuretic Peptide
  • 6.2.2. Creatine Kinase-MB [CK-MB] Fraction
  • 6.2.3. D-dimer Tests
  • 6.2.4. Myoglobin Tests
  • 6.2.5. Troponin Tests
• 6.3. Consumable & Accessories
• 6.4. Devices
  • 6.4.1. Analyzers
  • 6.4.2. Imaging & Monitoring Devices

7. Cardiac POC Testing Devices Market, by Device Type

• 7.1. Introduction
• 7.2. Bench-top POC Devices
• 7.3. Handheld POC Devices
• 7.4. Wearable POC Devices

8. Cardiac POC Testing Devices Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics & Screening
• 8.3. Monitoring

9. Cardiac POC Testing Devices Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Diagnostic Laboratories
• 9.4. Home Settings
• 9.5. Hospitals

10. Americas Cardiac POC Testing Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cardiac POC Testing Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac POC Testing Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Siemens Healthineers launches NT-proBNPII assay on Atellica platform to enhance heart failure diagnosis and speed patient care
  • 13.3.2. F. Hoffmann-La Roche AG launches NT-proBNP point-of-care test on cobas h 232 to enhance early detection and management of CVD and heart failure in diabetes patients
  • 13.3.3. Analytics for Life and CorVista Health receive FDA clearance for non-invasive CorVista System with Pulmonary Hypertension
  • 13.3.4. Eko Health, Inc. and Mayo Clinic secure FDA clearance for AI-driven low ejection fraction detection
  • 13.3.5. SpinChip Diagnostics receives NOK 115 million investment from bioMerieux to commercialize next-generation cardiac POC testing devices
  • 13.3.6. Roche to acquire LumiraDx's microfluidic point-of-care technology to advance cardiovascular diagnostics
  • 13.3.7. Primary Healthtech's Mobilab device offers early detection of heart and chronic diseases with IoT integration
  • 13.3.8. EDX Medical Group Plc. acquires Hutano Diagnostics Ltd. to develop advanced smartphone-integrated POC tests
  • 13.3.9. EDX Medical Group acquires Hutano Diagnostics to revolutionize rapid healthcare tests with advanced diagnostic technology enhancing speed, accuracy, and cost-effectiveness
  • 13.3.10. Cipla launches cippoint, POC testing device to expand diagnostics portfolio with CE IVD approval, enhancing rapid clinical decision-making and market penetration
• 13.4. Strategy Analysis & Recommendation
  • 13.4.1. F. Hoffmann-La Roche Ltd.
  • 13.4.2. Siemens Healthineers AG
  • 13.4.3. Abbott Laboratories
  • 13.4.4. Danaher Corporation
  • 13.4.5. Werfen, S.A.

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACON Laboratories, Inc.
• 3. Alfa Scientific Designs, Inc.
• 4. Bio-Rad Laboratories, Inc.
• 5. Cipla Limited
• 6. Compagnie Merieux Alliance SAS
• 7. Danaher Corporation
• 8. F. Hoffmann-La Roche Ltd
• 9. Getein Biotech, Inc.
• 10. Laboratory Corporation of America Holdings
• 11. LifeSign LLC
• 12. Medtronic plc
• 13. Merck KGaA
• 14. Nano-Ditech Corp.
• 15. Nexus Dx, Inc.
• 16. Nova Biomedical Corporation
• 17. Polymer Technology Systems, Inc. by Sinocare
• 18. Precision Biosensor, Inc.
• 19. QuidelOrtho Corporation
• 20. Sekisui Chemical Co., Ltd.
• 21. Siemens Healthineers AG
• 22. Werfen, S.A.